Mannkind (MNKD) Receivables (2014 - 2026)
Mannkind (MNKD) reported Receivables of $28.1 million for Q1 2026, down 2.64% year-over-year from $28.9 million in Q1 2025, and down 26.66% quarter-over-quarter from $38.4 million in Q4 2025.
Mannkind (MNKD) Receivables (2014 - 2026) Analysis & Trends
Mannkind (MNKD) has 13 years of Receivables data on file, last reported at $28.1 million in Q1 2026.
- Receivables for Q1 2026 came in at $28.1 million, down 2.64% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.1 million (down 2.64% YoY), and the FY2025 annual result was $38.4 million, up 225.03% from the prior year.
- Receivables declined to $28.1 million in Q1 2026 per MNKD's latest filing, from $38.4 million in the prior quarter.
- Over five years, Receivables peaked at $38.4 million in Q4 2025 and troughed at $900000.0 in Q1 2023.
- A 5-year average of $20.3 million and a median of $19.9 million in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2023 and 2024: Receivables plunged 91.28% in 2023, then jumped 2112.44% in 2024.
- A 5-year view of Receivables shows it stood at $16.8 million in 2022, then fell by 11.31% to $14.9 million in 2023, then decreased by 20.78% to $11.8 million in 2024, then soared by 225.03% to $38.4 million in 2025, then retreated by 26.66% to $28.1 million in 2026.
- Business Quant data shows MNKD's Receivables at $28.1 million in Q1 2026, $38.4 million in Q4 2025, and $17.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 28.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.14 Mn |
| Dec 31, 2025 | 38.37 Mn |
| Sep 30, 2025 | 17.38 Mn |
| Jun 30, 2025 | 27.14 Mn |
| Mar 31, 2025 | 28.90 Mn |
| Dec 31, 2024 | 11.80 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Jun 30, 2024 | 23.35 Mn |
| Mar 31, 2024 | 19.91 Mn |
| Dec 31, 2023 | 14.90 Mn |
| Sep 30, 2023 | 22.22 Mn |
| Jun 30, 2023 | 27.99 Mn |
| Mar 31, 2023 | 900,000.00 |
| Dec 31, 2022 | 16.80 Mn |
| Sep 30, 2022 | 24.09 Mn |
| Jun 30, 2022 | 15.43 Mn |
| Mar 31, 2022 | 10.32 Mn |
| Dec 31, 2021 | 5.04 Mn |
| Sep 30, 2021 | 9.45 Mn |
| Jun 30, 2021 | 6.31 Mn |